Selected Sleep Disorders: Restless Legs Syndrome and Periodic Limb Movement Disorder, Sleep Apnea Syndrome, and Narcolepsy

Psychiatric Clinics of North America

Volumn 29, Issue 4, 2006, Pages 947-967

  Erman, Milton K ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Pacific Sleep Medicine Services   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; ASCORBIC ACID; BENZODIAZEPINE DERIVATIVE; BROMOCRIPTINE; CARBAMAZEPINE; CARBIDOPA PLUS LEVODOPA; CLOMIPRAMINE; CLONAZEPAM; CODEINE; DESIPRAMINE; DEXAMPHETAMINE; DEXTROPROPOXYPHENE; FERROUS SULFATE; FLUOXETINE; GABAPENTIN; HYDROCODONE; IMIPRAMINE; IRON; METHADONE; METHYLPHENIDATE; MODAFINIL; OXYBATE SODIUM; OXYCODONE; PEMOLINE; PERGOLIDE; PRAMIPEXOLE; PROTRIPTYLINE; ROPINIROLE; SEROTONIN UPTAKE INHIBITOR; VENLAFAXINE;

ANOREXIA; ANXIETY; BARIATRIC SURGERY; BREATHING PATTERN; CLINICAL FEATURE; CONSTIPATION; DIAGNOSTIC VALUE; DISEASE EXACERBATION; DIZZINESS; DOPAMINERGIC SYSTEM; DRUG INDUCED HEADACHE; ELECTROENCEPHALOGRAM; ELECTROMYOGRAM; ELECTROOCULOGRAM; FOOD INTAKE; HEART PALPITATION; HUMAN; HYPERTENSION; INDIGESTION; INSOMNIA; IRON DEFICIENCY; LIVER TOXICITY; MENTAL DISEASE; MOTOR DYSFUNCTION; NARCOLEPSY; NAUSEA; NERVOUSNESS; NONHUMAN; NONREM SLEEP; ORTHOSTATIC HYPOTENSION; PAIN; PATHOPHYSIOLOGY; PERIODIC LIMB MOVEMENT DISORDER; PERIPHERAL NEUROPATHY; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PSYCHOSIS; QUALITY OF LIFE; RADIOFREQUENCY ABLATION; REM SLEEP; RESTLESS LEGS SYNDROME; RESTLESSNESS; REVIEW; SEDATION; SEXUAL DYSFUNCTION; SLEEP APNEA SYNDROME; SLEEP DISORDER; SOMNOLENCE; STANDING; TACHYCARDIA; TREMOR; URINE RETENTION; UVULOPALATOPHARYNGOPLASTY; VOMITING; WEIGHT REDUCTION; XEROSTOMIA;

CONTINUOUS POSITIVE AIRWAY PRESSURE; DRUG THERAPY; HLA-DR2 ANTIGEN; HUMANS; NARCOLEPSY; NOCTURNAL MYOCLONUS SYNDROME; POLYSOMNOGRAPHY; RESTLESS LEGS SYNDROME; SLEEP APNEA SYNDROMES; SLEEP APNEA, OBSTRUCTIVE; SLEEP, REM;

EID: 33750991599     PISSN: 0193953X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psc.2006.09.007     Document Type: Review

References (34)

1. Rosen R., Mahowald M., Chesson A., et al. The Taskforce 2000 Survey: medical education in sleep and sleep disorders. Sleep 21 (1998) 235-238
2. Kushida C.A., Littner M.R., Morgenthaler T., et al. Practice parameters for the indications for polysomnography and related procedures: an update for 2005. Sleep 28 (2005) 499-521
3. Flemons W.W. Clinical practice: obstructive sleep apnea. N Engl J Med 347 (2002) 498-504
4. Chesson Jr. A.L., Berry R.B., and Pack A. Practice parameters for the use of portable monitoring devices in the investigation of suspected obstructive sleep apnea in adults. Sleep 26 (2003) 907-913
5. El-Ad B., and Lavie P. Effect of sleep apnea on cognition and mood. Int Rev Psychiatry 17 (2005) 277-282
6. Suhner A.G., Darko D.D., Erman M.K., et al. Depressive symptoms in patients with OSA and the impact of nasal CPAP treatment. Sleep 25 (2003) A225
7. Young T., Palta M., Dempsey J., et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328 (1993) 1230-1235
8. Fujita S., Conway W., Zorick F., et al. Surgical correction of anatomic abnormalities in obstructive sleep apnea syndrome: uvulopalatopharyngoplasty. Otolaryngol Head Neck Surg 89 (1981) 923-934
9. Crookes P.F. Surgical treatment of morbid obesity. Annu Rev Med 57 (2006) 243-264
10. Walker-Engstrom M.L., Tegelberg A., Wilhelmsson B., et al. 4-year follow up of treatment with dental appliance or uvulopalatopharyngoplasty in patients with obstructive sleep apnea: a randomized study. Chest 121 (2002) 739-746
11. Hanzel D.A., Proia N.G., and Hudgel D.W. Response of obstructive sleep apnea to fluoxetine and protriptyline. Chest 100 (1991) 416-421
12. Daniels L. Narcolepsy. Medicine (Baltimore) 13 (1934) 1-22
13. Yoss R.E., and Daly D.D. Criteria for the diagnosis of the narcoleptic syndrome. Mayo Clin Proc 32 (1957) 320-328
14. Vogel G. Studies in psychophysiology of dreams: III. the dream of narcolepsy. Arch Gen Psychiatry 3 (1960) 421-428
15. Carskadon M.A., Dement W.C., Mitler M.M., et al. Guidelines for the multiple sleep latency test (MSLT): a standard measure of sleepiness. Sleep 9 (1986) 519-524
16. Scammell T.E. The neurobiology, diagnosis, and treatment of narcolepsy. Ann Neurol 53 (2003) 154-166
17. Honda Y., Asake A., Tanaka Y., et al. Discrimination of narcolepsy by using genetic markers and HLA. Sleep Res 12 (1983) 254
18. Littner M.R., Kushida C., Wise M., et al. Practice parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness test. Sleep 28 (2005) 113-121
19. American Academy of Sleep Medicine. International classification of sleep disorders: diagnostic and coding manual. 2nd edition (2005), American Academy of Sleep Medicine, Westchester (IL)
20. Mignot E. Genetic and familial aspects of narcolepsy. Neurology 50 Suppl 1 (1998) S16-S22
21. Juji T., Matsuki K., Tokunaga K., et al. Narcolepsy and HLA in the Japanese. Ann N Y Acad Sci 540 (1988) 106-114
22. Lin L., Faraco J., Li R., et al. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 98 (1999) 365-376
23. Chemelli R.M., Sinton C.M., and Yanagisawa M. Polysomnographic characterization of orexin-2 receptor knockout mice. Sleep 23 (2005) A296-A297
24. Nishino S., Ripley B., Overeem S., et al. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 355 (2000) 39-40
25. Goswami M. The influence of clinical symptoms on quality of life in patients with narcolepsy. Neurology 50 Suppl 1 (1998) S31-S36
26. Mitler M., Erman M., and Hajdukovic R. The treatment of excessive somnolence with stimulant drugs. Sleep 16 (1993) 203-206
27. Thorpy M., Black J., Erman M., et al. Tolerability of modafinil in disorders of sleep and wakefulness. Sleep 27 (2004) A130
28. Schwartz J.R., Hirshkowitz M., Erman M.K., et al. Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea: a 12-week, open-label study. Chest 124 (2003) 2192-2199
29. Ballon J.S., and Feifel D. A systematic review of modafinil: potential clinical uses and mechanisms of action. J Clin Psychiatry 67 (2006) 554-566
30. Mamelak M., Scharf M.B., and Woods M. Treatment of narcolepsy with gamma-hydroxybutyrate: a review of clinical and sleep laboratory findings. Sleep 9 (1986) 285-289
31. Harsh J.R., Hayduk R., Rosenberg R., et al. The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy. Curr Med Res Opin 22 (2006) 761-774
32. Phillips B., Young T., Finn L., et al. Epidemiology of restless legs symptoms in adults. Arch Intern Med 160 (2000) 2137-2141
33. Trenkwalder C., Garcia-Borreguero D., Montagna P., et al. Ropinirole in the treatment of restless legs syndrome: results from the TREAT RLS 1 study, a 12 week, randomised, placebo controlled study in 10 European countries. J Neurol Neurosurg Psychiatry 75 (2004) 92-97
34. Bogan R.K., Fry J.M., Schmidt M.H., et al. Ropinirole in the treatment of patients with restless legs syndrome: a US-based placebo-controlled clinical trial. Mayo Clin Proc 81 (2006) 17-27